Probiotics for Ulcerative Colitis, Crohn's Disease and Pouchitis: What Evidence Exists
What Cochrane reviews, AGA guidelines and meta-analyses found for probiotics in ulcerative colitis, Crohn's disease and pouchitis, and why a gastroenterologist should lead.
Content last updated . This page has not been medically reviewed.
Read this first
Ulcerative colitis and Crohn's disease need specialist care. The NHS (UK) lists very bad or bloody diarrhea, high temperature, fast heartbeat, or being unable to pass wind or stool as reasons for urgent advice. [1] Non-stop bleeding from the bottom is an emergency; in the US call 911. [1] Do not stop or change a prescribed IBD medicine because of a probiotic. Ask your gastroenterologist or pharmacist first.The NHS describes treatment as aimed at easing symptoms during a flare-up and reducing the chances of it coming back, using medicines that can include immunosuppressants. [1] The NHS page does not list probiotics among those treatments.
The short answer
- Ulcerative colitis: low-certainty evidence that some probiotics may add to remission rates when used with standard treatment, and unclear evidence for keeping remission. The AGA said use only in clinical trials. [2][3][4]
- Crohn's disease: no evidence of benefit in the sources we read. [5][6]
- Pouchitis (inflammation of the surgically created pouch after colon removal for ulcerative colitis): the most consistent signal, but for specific products and with low-quality data. [7][8]
What reviews and guidelines found
| Question | What the source found | Label |
|---|---|---|
| UC, inducing remission | Cochrane 2020 (14 studies, 865 people, mostly mild to moderate UC): probiotics may induce clinical remission versus placebo (RR 1.73, low certainty). [2] | Promising but limited |
| UC, inducing remission, evidence limits | No evidence for severe or extensive disease; high risk of bias in all but two studies. [2] | Insufficient evidence |
| UC, maintaining remission | Cochrane 2020 (12 studies, 1,473 people): effectiveness remains unclear; evidence low to very low certainty. [3] | Insufficient evidence |
| UC, standard treatment plus probiotic | AGA technical review: does not appear to improve overall remission rates in mild-to-moderate UC. [5] | Mixed |
| UC, endoscopy | A 2024 overview and meta-analysis: probiotics not associated with better endoscopic outcomes; overall certainty low. [9] | No good evidence of benefit |
| Crohn's disease | AGA: no evidence that probiotics help induce or maintain remission. [5] NCCIH: no evidence of benefit in a 2014 review. [6] A 2024 meta-analysis: no significant effect. [9] | No good evidence of benefit |
| Pouchitis, prevention | Meta-analysis of trials (published 2025): relative risk 0.18 for primary and 0.17 for secondary prevention; low-quality data. [8] | Promising but limited |
Strain and product details
Cochrane's induction review included seven single-strain and seven mixed-strain studies. [2] The 2024 meta-analysis suggested multi-strain formulations looked better in UC, but it also rated overall certainty low. [9] It pooled studies of different products, so it cannot tell you which product works.For pouchitis, the AGA (US, 2020) suggested one 8-strain combination (L. paracasei subsp. paracasei, L. plantarum, L. acidophilus, L. delbrueckii subsp. bulgaricus, B. longum subsp. longum, B. breve, B. longum subsp. infantis and S. salivarius subsp. thermophilus) over no or other probiotics. It called this conditional, with very low-quality evidence, and said people for whom cost or feasibility is a problem could reasonably choose none. [4] In 2024 the AGA suggested probiotics to prevent recurrent pouchitis in people whose episodes respond to antibiotics, one of nine conditional recommendations. [7] Results for one product do not carry over to others. [10]
Frequently asked questions
Do probiotics treat ulcerative colitis?
They may add to remission when combined with standard treatment, according to low-certainty Cochrane evidence, but they are not a replacement for medicine. [2]
Do probiotics help Crohn's disease?
The sources we read found no evidence of benefit. [5][9]
Do probiotics help pouchitis?
Meta-analyses and AGA guidelines support specific products for preventing recurrence, with low-quality evidence. [7][8]
Can I take a probiotic while on IBD medicine?
Ask your gastroenterologist or pharmacist. Immunosuppression changes the risk. [6]
Which probiotic is best for IBD?
Proper evidence not found for a single best product; results are strain-specific. [10]
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
How to read the evidence labels
Labels used on this page: promising but limited, mixed, insufficient evidence, no good evidence of benefit, Proper evidence not found. Study amounts are not advice.
Limits and uncertainty
- Cochrane found high risk of bias in all but two induction studies. [2]
- The 2025 pouch meta-analysis said the overall data quality was low and more research is needed. [8]
- Studies mostly tested mild to moderate disease. [2]
- Proper evidence not found, in the sources we read, for probiotics in people already taking biologics or small-molecule IBD drugs, or for IBD in children specifically.
Safety and who should ask first
References
- NHS, Ulcerative colitis. Read 2026-10-22.
- Kaur L et al., Probiotics for induction of remission in ulcerative colitis, Cochrane Database Syst Rev 2020. Read 2026-10-22.
- Iheozor-Ejiofor Z et al., Probiotics for maintenance of remission in ulcerative colitis, Cochrane Database Syst Rev 2020. Read 2026-10-22.
- Su GL et al., AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders, Gastroenterology 2020. Read 2026-10-22.
- Preidis GA et al., AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders, Gastroenterology 2020. Read 2026-10-22.
- NCCIH, Probiotics: Usefulness and Safety. Read 2026-10-22.
- Barnes EL et al., AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders, Gastroenterology 2024. Read 2026-10-22.
- Syal G et al., Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders: A Systematic Review and Meta-Analysis, Am J Gastroenterol 2025. Read 2026-10-22.
- Estevinho MM et al., Efficacy and safety of probiotics in IBD: an overview of systematic reviews and updated meta-analysis of randomized controlled trials, United European Gastroenterol J 2024. Read 2026-10-22.
- McFarland LV et al., Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis, Front Med 2018. Read 2026-10-22.
- NHS, Probiotics. Read 2026-10-22.
- Peery AF et al., AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases, Gastroenterology 2024. Read 2026-10-22.